Catherine Priestley
PUBLISHED ON: 5 May 2017

During a pause in its appraisal by NICE the drug, palbociclib (Ibrance), is being made available to suitable secondary breast cancer patients. Our Clinical Nurse Specialist explains more.

Emma holds up a card with a sign saying: '90% of people living with secondary breast cancer said they'd been in pain in the last month.'
PUBLISHED ON: 12 October 2015

Emma was diagnosed with secondary breast cancer four years ago. She shares her bucket list and explains the one thing she thinks the government could do to help people like her.